This is part four in a five-part series called "The Limits of Accelerating Returns" that focuses on the limitations of Ray Kurzweil's Law of Accelerating Returns when applied to molecular biology and biomedical technology, including longevity treatments. The other articles in the series are "The Limits of Accelerating Returns," "Biology is not Digital," "Garbage In, Garbage Out," and "Implications of Fixed Returns."
In the previous post in this series, I suggested that, in 40 years, we will be able to run complex molecular simulations of the entire human body if the limiting factor is computational power. Unfortunately, that’s just not the case. We can’t generate the requisite data fast enough for the computers to crunch it. Not everything is amenable to accelerating returns.
